{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:32Z","timestamp":1787237492012,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbadis.2026.168238","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:09:45Z","timestamp":1775059785000},"page":"168238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["H3K27ac-induced IFITM3 promotes progression of TNBC and resistance to anti-PD-1\/PD-L1 therapy via the TNF-\u03b1\/NF-\u03baB\/PD-L1 axis"],"prefix":"10.1016","volume":"1872","author":[{"given":"Guangyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2026.168238_bb0005","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1038\/s41467-022-35059-x","article-title":"EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis","volume":"13","author":"Verma","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168238_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clbc.2024.03.001","article-title":"The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)","volume":"24","author":"Michaels","year":"2024","journal-title":"Clin. Breast Cancer"},{"issue":"7","key":"10.1016\/j.bbadis.2026.168238_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071033","article-title":"PD-1\/PD-L1 targeting in breast cancer: the first clinical evidences are emerging. A literature review","volume":"11","author":"Planes-Laine","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168238_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000453569","article-title":"PD-1 and PD-L1 immune checkpoint blockade to treat breast cancer","volume":"11","author":"Hartkopf","year":"2016","journal-title":"Breast Care (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168238_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010104","article-title":"Mechanisms and strategies to overcome PD-1\/PD-L1 blockade resistance in triple-negative breast cancer","volume":"15","author":"Chen","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168238_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12943-020-1144-6","article-title":"Predictive biomarkers and mechanisms underlying resistance to PD1\/PD-L1 blockade cancer immunotherapy","volume":"19","author":"Ren","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168238_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5612138","article-title":"Interferon-induced transmembrane protein 3 expression upregulation is involved in progression of hepatocellular carcinoma","volume":"2021","author":"Hou","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168238_bb0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41419-019-1750-7","article-title":"IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-\u03b2 signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168238_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102741","article-title":"IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity","volume":"299","author":"G\u00f3mez-Herranz","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168238_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593245","article-title":"Malignancy and IFITM3: friend or foe?","volume":"10","author":"Rajapaksa","year":"2020","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168238_bb0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41588-021-00842-x","article-title":"Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci","volume":"53","author":"Sungalee","year":"2021","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168238_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/17501911.2025.2460900","article-title":"A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer","volume":"17","author":"Zhu","year":"2025","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168238_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00439-024-02646-5","article-title":"STEAP3 promotes colon cancer cell proliferation and migration via regulating histone acetylation","volume":"143","author":"Lv","year":"2024","journal-title":"Hum. Genet."},{"issue":"52","key":"10.1016\/j.bbadis.2026.168238_bb0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2408049121","article-title":"ACSL4-mediated H3K9 and H3K27 hyperacetylation upregulates SNAIL to drive TNBC metastasis","volume":"121","author":"Sinha","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.bbadis.2026.168238_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122872","article-title":"CBP\/p300: critical co-activators for nuclear steroid hormone receptors and emerging therapeutic targets in prostate and breast cancers","volume":"13","author":"Waddell","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2026.168238_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.886594","article-title":"Lysine acetyltransferases and their role in AR signaling and prostate cancer","volume":"13","author":"Jaiswal","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168238_bb0085","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168238_bb0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cncr.23551","article-title":"Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis","volume":"113","author":"Fan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2026.168238_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2377-13-210","article-title":"The role of IFITM3 in the growth and migration of human glioma cells","volume":"13","author":"Zhao","year":"2013","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168238_bb0100","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3892\/or.2014.3522","article-title":"Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer","volume":"32","author":"Hu","year":"2014","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168238_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/1759-7714.12451","article-title":"Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma","volume":"8","author":"Zhang","year":"2017","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168238_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13578-022-00858-8","article-title":"IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET\/AKT\/FOXO3\/c-MYC axis","volume":"12","author":"Chu","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbadis.2026.168238_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704965","article-title":"Interferon-induced transmembrane Protein 3 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168238_bb0120","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1158\/0008-5472.CAN-19-2400","article-title":"Targeted inhibition of the E3 ligase SCF(Skp2\/Cks1) has antitumor activity in RB1-deficient human and mouse small-cell lung cancer","volume":"80","author":"Zhao","year":"2020","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.bbadis.2026.168238_bb0125","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1158\/0008-5472.CAN-19-1302","article-title":"HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer","volume":"79","author":"Fukumoto","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168238_bb0130","doi-asserted-by":"crossref","first-page":"1133472","DOI":"10.3389\/fcell.2023.1133472","article-title":"Targeting the BRCA1\/2 deficient cancer with PARP inhibitors: clinical outcomes and mechanistic insights","volume":"11","author":"Ragupathi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168238_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41419-023-06303-z","article-title":"Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168238_bb0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-018-0651-5","article-title":"RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-\u03baB-mediated ERK reactivation","volume":"9","author":"Cho","year":"2018","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168238_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.24","article-title":"Inhibition of eIF2\u03b1 dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells","volume":"5","author":"Teng","year":"2014","journal-title":"Cell Death Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:21:17Z","timestamp":1780172477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0925443926001018"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168238","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H3K27ac-induced IFITM3 promotes progression of TNBC and resistance to anti-PD-1\/PD-L1 therapy via the TNF-\u03b1\/NF-\u03baB\/PD-L1 axis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168238"}}